pharmaphorum

DECEMBER 1, 2022

To ease this burden, the life sciences industry has been searching for ways to make clinical trials more accessible for patients and to drive participation numbers, increase participant diversity, and improve overall patient experience. Imagine, clinical research as an accessible care option to anyone.

Clinical Trials 104

Clinical Trials Clinical Trials Trials Clinical Research 104

The Pharma Data

SEPTEMBER 29, 2021

Heerspink, Professor of Clinical Trials and Personalized Medicine and a clinical pharmacologist/trialist at the Department of Clinical Pharmacy and Pharmacology at the University center Groningen, Netherlands, and Co-Chair of the study’s Executive Committee. “If

Clinical Development 52

Clinical Development Development Clinical Trials Clinical Trials 52

pharmaphorum

OCTOBER 7, 2021

Dr Jean-Meidi Alili is a senior pharmacist in charge of Medicines and Research at the French healthcare network for rare metabolic diseases (G2M), where he is notably involved in implementing a drugs observatory and two ‘one-stop-shops’ in research and pharmacy.

Genome 96

Genome Genomics Medicine Life Science 96

XTalks

APRIL 24, 2023

“Rare disease clinical trials are complex due to the additional scientific, medical, operational and regulatory requirements of newly emerging advanced therapies, such as gene therapy,” says Dr. Terence Eagleton, MB BS, Senior Medical Director at the global clinical research organization (CRO) Medpace.

Gene Therapy 95

Gene Therapy Gene Trials Clinical Trials 95

XTalks

SEPTEMBER 14, 2020

Xtalks has hosted some excellent webinars on navigating development and operations during the current pandemic, presented by leading experts in the pharmaceutical, biotechnology and food industries. Below are some free webinars you can register for that have delved into the topic: Continuing Clinical Research Innovations After COVID-19.

Vaccination 92

Vaccination Vaccine Antibody Life Science 92